-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
November 01, 2016 - Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults
Noninvasive Treatments
for Low Back Pain
A Summary of the Research for Adults
e
DRAFT: CONFIDENTIAL - For review only, not for dissemination - Task 3.7c- LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04
Archived: This
report i…
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
January 01, 2014 - Kineret (anakinra) prescribing information.
[internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management-future_research.pdf
June 01, 2015 - FRN 30: Outpatient Case Management for Adults With Medical Illnesses and Complex Care Needs: Future Research Needs
Future Research Needs Paper
Number 30
Outpatient Case
Management for
Adults With Medical
Illnesses and Complex
Care Needs: Future
Research Needs
Future Research Needs Paper
Number 30
Outpati…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
March 01, 2012 - treat epilepsy will now have access to an enriched
view of the available scientific evidence when prescribing … The key questions are on target with the
current controversial issues related to AED prescribing in … do not believe that brand drugs are superior to their
bioequivalent versions, but they provide the prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - Truvada (emtricitabine/tenofovir disoproxil
fumarate) tablets prescribing information. … DIFICID (fidaxomicin) tablets, for oral use
prescribing information. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - Layout 1
Background
Over 28 million Americans have some
form of cardiovascular disease (CVD),
which causes more deaths than cancer,
diabetes, accidents, and chronic lung
diseases combined. Estimated direct
medical expenditures and lost productivity
from CVD amounted to $431.8 billion in
the United States in 2007.
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
April 01, 2010 - Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
March 01, 2010 - MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapi…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
August 13, 2012 - 7
Abstract
The steps involved in the process of developing research questions and study objectives for conducting
observational comparative effectiveness research (CER) are described in this chapter. It is important
to begin with identifying decisions under consideration, determining who the decisionmakers and
sta…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - 45
Abstract
Characterization of exposure is a central issue in the analysis of observational data; however, no “one
size fits all” solution exists for exposure measurement. In this chapter, we discuss potential exposure
measurement approaches for observational comparative effectiveness research (CER). First, it is …
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Victoza
(liraglutide (RDNA origin) injection) injection,
solution prescribing information.
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
June 01, 2010 - studies, particularly the recognition that intended effects are
more likely to be biased by preferential prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
June 01, 2010 - studies, particularly the recognition that intended effects are
more likely to be biased by preferential prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
December 15, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: April 28, 2011
Page 1 of 26
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Dietary Supplement Versus No Dietary
Supplement Use in Adults Taking Cardiovascular D…
-
effectivehealthcare.ahrq.gov/sites/default/files/interventions-horizon-scan-high-impact-1306.pdf
June 01, 2013 - be educated about their medications, and
potential to lessen the burden of care that rests on the prescribing
-
effectivehealthcare.ahrq.gov/health-topics/antidepressants
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - Published Online: February 11, 2014 35
Commentator Section Comments Response
individual before of prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
June 10, 2018 - Therefore,
caution is necessary when prescribing pharmacologic pain treatment, especially in certain
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
March 08, 2012 - Atrovent® (ipratropium bromide) nasal spray 0.06%: prescribing information. … docBase=renetnt&folderPath=/Prescribing+Infor
mation/PIs/Atrovent+Nasal+06/Atrovent006.pdf.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder-disposition-160504.pdf
December 08, 2015 - John's wort are
generally not included in drug-drug interaction checking software
including electronic prescribing … While that dosage is within the normal
prescribing range, we understand
how the upper limit could result … While that dosage
is within the normal prescribing range,
we understand how the upper limit
could